Skip to main content

Table 3 Effect of sugammadex on postoperative recovery, based on a propensity score-matched cohorts

From: Analysis of the association of sugammadex with the length of hospital stay in patients undergoing abdominal surgery: a retrospective study

Outcome

Crude

Adjust I

Adjust II

β (95% CI)

P value

β (95% CI)

P value

β (95% CI)

P value

First feces’ time (days)

−0.24 (− 0.44, − 0.03)

0.0217

− 0.24 (− 0.44, − 0.04)

0.0188

−0.25 (− 0.45, − 0.05)

0.0129

Postoperative ambulation time

−0.46 (− 0.67, − 0.26)

< 0.0001

−0.48 (− 0.69, − 0.27)

< 0.0001

−0.43 (− 0.62, − 0.23)

< 0.0001

Postoperative hospital stay (days)

−0.35 (−1.26, 0.55)

0.4439

− 0.41 (− 1.32, 0.49)

0.3701

−0.29 (− 1.13, 0.54)

0.4912

The length of PACU stay (min)

−19.78 (−23.11, − 16.46)

< 0.0001

−19.96 (− 23.24, − 16.67)

< 0.0001

−20.30 (− 23.48, −17.11)

< 0.000

  1. Non-adjusted model adjust for: None
  2. Adjust I adjust for: sex; age; ASA; BMI; hypertension; diabetes; cerebral infarction; smoking history; drinking; heart disease
  3. Adjust II adjust for: operation duration (minutes); dosage of muscle relaxant (mg); laparoscopic surgery; type of surgery; total remifentanil